The convergence of advances in medical science, human biology, data science, and technology has enabled a generation of new insights into the phenotypes underlying the diagnosis of diabetes. Deeper knowledge of these conditions has emerged from populations around the world, illuminating the differences in how diabetes presents, its variable prevalence, and how best practice in treatment varies across populations. In precision medicine, diagnostic tests help optimize a patient’s treatment strategies. Precision medicine proposes custom delivery of health care, with medical practices, testing, decisions, and treatments tailored to the individual patient level, basically, identifying the right treatment, for each patient, at the right time.
ADA has partnered with the European Association for the Study of Diabetes (EASD) on the Precision Medicine in Diabetes Initiative (PMDI) and our work in precision medicine’s innovative and pioneering technology is providing the foundation for great strides in advancements in diabetes care.